Evidence map›Paper›PMID 40206562›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2025

[Political support and micro-planning as success factors in a high-quality follow-up vaccination campaign in Ecuador, 2023Apoio político e microplanejamento como fatores de sucesso em uma campanha de vacinação de seguimento de alta qualidade no Equador em 2023].

Gabriela Aguinaga-Romero, Cristina Jacome, Jonathan Márquez, Jackeline Pinos, Ania Carmenates, Daniel Simancas-Racines, Juan Marcos Parise-Vasco, Andrés Viteri-García, Álvaro Withembury, Yndira Anchayhua and 1 more

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gabriela Aguinaga-RomeroUniversidad Central del Ecuador Quito Ecuador Universidad Central del Ecuador, Quito, Ecuador.
Cristina JacomeDirección Nacional de Inmunizaciones Ministerio de Salud Pública del Ecuador Quito Ecuador Dirección Nacional de Inmunizaciones, Ministerio de Salud Pública del Ecuador, Quito, Ecuador.
Jonathan MárquezDirección Nacional de Inmunizaciones Ministerio de Salud Pública del Ecuador Quito Ecuador Dirección Nacional de Inmunizaciones, Ministerio de Salud Pública del Ecuador, Quito, Ecuador.
Jackeline PinosDirección Nacional de Inmunizaciones Organización Panamericana de la Salud Quito Ecuador Dirección Nacional de Inmunizaciones, Organización Panamericana de la Salud, Quito, Ecuador.
Ania CarmenatesDirección Nacional de Inmunizaciones Organización Panamericana de la Salud Quito Ecuador Dirección Nacional de Inmunizaciones, Organización Panamericana de la Salud, Quito, Ecuador.
Daniel Simancas-RacinesCentro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC) Facultad de Ciencias de la Salud Eugenio Espejo Universidad UTE Quito Ecuador Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Juan Marcos Parise-VascoCentro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC) Facultad de Ciencias de la Salud Eugenio Espejo Universidad UTE Quito Ecuador Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Andrés Viteri-GarcíaUniversidad Internacional SEK Facultad de Ciencias de la Salud Quito Ecuador Universidad Internacional SEK, Facultad de Ciencias de la Salud, Quito, Ecuador.
Álvaro WithemburyAsesor internacional de inmunizaciones Organización Panamericana de la Salud Quito Ecuador Asesor internacional de inmunizaciones, Organización Panamericana de la Salud, Quito, Ecuador.
Yndira AnchayhuaConsultora internacional Organización Panamericana de la Salud Quito Ecuador Consultora internacional, Organización Panamericana de la Salud, Quito, Ecuador.
Regina DurónConsultora internacional de inmunizaciones Organización Panamericana de la Salud Washington D.C. Estados Unidos de América Consultora internacional de inmunizaciones, Organización Panamericana de la Salud, Washington D.C., Estados Unidos de América.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To describe the results, achievements, and lessons learned through administrative coverage and rapid monitoring of a follow-up vaccination campaign, in the context of political prioritization and micro-planning as determining factors in the different stages of follow-up campaigns, and the application of these good practices to strengthen the National Immunization Program. Method: This is a special descriptive epidemiological report on a high-quality follow-up vaccination campaign in Ecuador. The sources of information used were: population estimates from the 2010 and 2022 censuses carried out by the National Institute of Statistics and Census; calculation of the susceptible cohort for vaccination with the bivalent vaccine (measles and rubella) and with the oral and injectable polio vaccines; definition of vaccination strategies and tactics, and vaccine scheduling by type and age group; and macro- and micro-planning instruments generated at the local level, which involve quantitative variables related to human, material, logistic, and financial resources. Achievement of high-quality criteria and indicators for follow-up vaccination campaigns were also assessed, including effectiveness, homogeneity, timeliness, simultaneity, efficiency, and rapid monitoring. Results: The micro-planning process was fully implemented nationwide in 95% of health facilities (1879) four weeks prior to implementation of the follow-up campaign. High-quality follow-up was conducted over 14 weeks: 3 395 716 children aged 1-12 years were vaccinated and 99% administrative coverage was achieved, with 71% of provinces (17) reaching ≥95% coverage. In the remaining 29% of provinces (7), coverage rates were between 90% and 94%, with a total of 5 556 128 doses of bivalent vaccine and oral or injectable polio vaccine. Based on the quality criteria, the country achieved 95% of the targeted results. Conclusions: Political support and prioritization, together with the implementation of high-quality micro-planning of the follow-up vaccination campaign generated at the local level, enabled the achievement of targets and results at ≥95% coverage. This is an innovative and successful public health experience that has strengthened the National Immunization Program in Ecuador and other countries in the Region of the Americas. Local health teams conducted micro-planning adapted to the local context, using the methodology and instruments to identify areas of responsibility in orderly, systematic intramural and extramural vaccination campaigns.

Indexed as

coverageEcuadorhealth prioritiesimmunizationVaccines

Identifiers

PMID40206562
PMCPMC11980522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.